Michael E. Tarnoff - 19 Jul 2023 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Reporting relationship: Director
Issuer ticker: ANGO
Reported as of: 19 Jul 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jul 2023, 21:11:03 UTC
Prior SEC filing: 22 Jul 2022
Next SEC filing: 19 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Stephen A. Trowbridge, Attorney in Fact

Key filing fact

Michael E. Tarnoff filed Form 4 for ANGIODYNAMICS INC (ANGO) on 21 Jul 2023.

Key facts

This page summarizes Michael E. Tarnoff's Form 4 filing for ANGIODYNAMICS INC (ANGO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Jul 2023, 21:11.

Change

Previous filing in this sequence was filed on 22 Jul 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANGO transaction

Common Stock

Award

Transaction value: $0
Shares: +17,041
Change %: +61%
Price: $0.000000
Shares after: 45,162
Date: 19 Jul 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The acquisition of 17,041 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,041 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.